Search Contract Opportunities

Continuing Access to Harvard Longitudinal Survey Data

ID: FDA_7222026 • Type: Special Notice • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Loading

Description

Cross-sectional data sets, such as derived from the National Health and Nutritional Examination Survey (NHANES), are readily available at no cost over the web, and analyses of such data sets can help suggest potential associations between dietary intake exposures and health outcomes. However, because cross- sectional surveys collect exposure and outcome data at the very same point in time, they cannot help us understand if exposures through routine dietary intake and other exposures related to regulated products preceded diagnosis of adverse health conditions.

Longitudinal data often collected repeatedly from participants in prospective cohort studies conducted over several years help to reveal relationships between dietary and environmental exposures and the development of health conditions over time. The FDA Human Foods Program (HFP)/Office of Surveillance Strategy and Risk Prioritization (OSSRP)/Division of Evaluation and Population Health Science (DEPHS)/Epidemiology and Medical Sciences Branch (EMSB) is interested in obtaining such longitudinal data from the ongoing President and Fellows of Harvard College/Harvard School of Public Health (HSPH) longitudinal studies:

  • Nurses' Health Study original cohort (NHS: ~122,000 participants, since 1976)
  • Nurses' Health Study II (NHSII: ~116,000 participants, began in 1989)
  • Health Professionals Follow-Up Study (HPFS: ~100,000 men, since 1986)
  • Growing Up Today Study (GUTS: children of NHS participants, including 16,882 girls and boys; since 1996)
  • Growing Up Today Study 2 (GUTS2: children of NHSII participants, including 10,923 girls and boys; since 2004)

Analyses of longitudinal data from these studies will help monitor diet and lifestyle risk factors, allow for scientific evaluation of potential causal links between these factors and chronic disease incidence, and enhance understanding of individual and intergenerational relationships between dietary intake, lifestyle exposures, and chronic conditions/long-term health effects throughout the lifespan, among parents and offspring, including evaluating grandmother-maternal-child outcomes. This information will help the FDA improve dietary policy and consumer education to protect and promote public health.
Please see attched SOW.

Overview

Response Deadline
Aug. 7, 2026, 3:00 p.m. EDT Due in 15 Days
Posted
July 22, 2026, 12:35 p.m. EDT
Set Aside
8(a) Sole Source (8AN)
PSC
None
Place of Performance
Rockville, MD 20852 United States
Source

Current SBA Size Standard
$40 Million
Pricing
Likely Fixed Price
Est. Value Range
Experimental
$250,000 - $900,000 (AI estimate)
Signs of Shaping
87% of obligations for similar contracts within the Food and Drug Administration were awarded full & open.
On 7/22/26 Food and Drug Administration issued Special Notice FDA_7222026 for Continuing Access to Harvard Longitudinal Survey Data due 8/7/26.
Primary Contact
Name
Samad Sahil
Phone
None

Documents

Posted documents for Special Notice FDA_7222026

Opportunity Assistant


AI Analysis

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice FDA_7222026

Similar Active Opportunities

Open contract opportunities similar to Special Notice FDA_7222026

Experts for Continuing Access to Harvard Longitudinal Survey Data

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION
FPDS Organization Code
7524-7524
Source Organization Code
100008023
Last Updated
July 22, 2026
Last Updated By
samad.sahil@fda.hhs.gov
Archive Date
Aug. 22, 2026